{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:10:00Z","timestamp":1792091400892,"version":"4.4.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>One of the most debilitating drawbacks of cisplatin chemotherapy is neurotoxicity which elicits memory impairment and cognitive dysfunction (chemobrain). This is primarily triggered by oxidative stress and inflammation. Captopril, an angiotensin-converting enzyme inhibitor, has been reported as a neuroprotective agent owing to its antioxidant and anti-inflammatory effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We examined the possible neuroprotective effect of captopril against cisplatin-induced neurological and behavioral abnormalities in rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Chemobrain was induced in rats by cisplatin (5\u00a0mg\/kg, i.p.) on the 7th and 14th days of the study while captopril was administered orally (25\u00a0mg\/kg) daily for three weeks. The effects of captopril were assessed by performing behavioral tests, histological examination, and evaluation of oxidative stress and inflammatory markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cisplatin caused learning\/memory dysfunction assessed by passive avoidance and Y-maze tests, decline in locomotion, and rotarod motor balance loss which were further verified by neurodegeneration observed in histological examination. Also, cisplatin aggravated oxidative stress by elevating lipid peroxidation (MDA) levels and diminishing catalase activity. Moreover, cisplatin upregulated the neuroinflammatory markers (TNF, IL-6, GFAP, and NF-\u03baB). Captopril successfully ameliorated cisplatin damage on the levels of neurobehavioral and histopathological changes. Mechanistically, captopril significantly diminished MDA production and preserved catalase antioxidant activity. Captopril also counteracted neuroinflammation through inhibiting NF-\u03baB and its downstream proinflammatory cytokines besides repressing astrocyte activity by reducing GFAP expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our findings revealed that captopril could abrogate cisplatin neurotoxicity\n                      <jats:italic>via<\/jats:italic>\n                      reducing oxidative stress and neuroinflammation thus enhancing cognitive and behavioral performance. This could suggest the repurposing of captopril as a neuroprotective agent, especially in hypertensive cancer patients receiving cisplatin.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00213-024-06706-6","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T18:20:21Z","timestamp":1736878821000},"page":"563-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Captopril attenuates oxidative stress and neuroinflammation implicated in cisplatin-induced cognitive deficits in rats"],"prefix":"10.1007","volume":"242","author":[{"given":"Fatma","family":"Mostafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Mantawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham S.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar S.","family":"Azab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2951-4892","authenticated-orcid":false,"given":"Ebtehal","family":"El-Demerdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"6706_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/J.LFS.2016.10.026","volume":"167","author":"A Abareshi","year":"2016","unstructured":"Abareshi A, Hosseini M, Beheshti F et al (2016) The effects of captopril on lipopolysaccharide induced learning and memory impairments and the brain cytokine levels and oxidative damage in rats. Life Sci 167:46\u201356. https:\/\/doi.org\/10.1016\/J.LFS.2016.10.026","journal-title":"Life Sci"},{"key":"6706_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.30466\/VRF.2018.90760.2198","volume":"10","author":"A Abareshi","year":"2019","unstructured":"Abareshi A, Anaeigoudari A, Norouzi F et al (2019) The effects of captopril on lipopolysaccharide-induced sickness behaviors in rats. Veterinary Res Forum 10:199\u2013205. https:\/\/doi.org\/10.30466\/VRF.2018.90760.2198","journal-title":"Veterinary Res Forum"},{"key":"6706_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/J.EXPNEUROL.2016.06.004","volume":"283","author":"AK Abdel-Aziz","year":"2016","unstructured":"Abdel-Aziz AK, Mantawy EM, Said RS, Helwa R (2016) The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries. Exp Neurol 283:129\u2013141. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2016.06.004","journal-title":"Exp Neurol"},{"key":"6706_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/S00210-018-1497-1","volume":"391","author":"RG Abdel-latif","year":"2018","unstructured":"Abdel-latif RG, Heeba GH, Taye A, Khalifa MMA (2018) Lixisenatide, a novel GLP-1 analog, protects against cerebral ischemia\/reperfusion injury in diabetic rats. Naunyn-Schmiedeberg\u2019s Archives Pharmacol 391:705\u2013717. https:\/\/doi.org\/10.1007\/S00210-018-1497-1","journal-title":"Naunyn-Schmiedeberg\u2019s Archives Pharmacol"},{"key":"6706_CR5","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2147\/DDDT.S191240","volume":"13","author":"WM Abdel-Wahab","year":"2019","unstructured":"Abdel-Wahab WM, Moussa FI (2019) Neuroprotective effect of N-acetylcysteine against cisplatin-induced toxicity in rat brain by modulation of oxidative stress and inflammation. Drug Des Devel Ther 13:1155\u20131162. https:\/\/doi.org\/10.2147\/DDDT.S191240","journal-title":"Drug Des Devel Ther"},{"key":"6706_CR6","first-page":"91","volume":"23","author":"HR Akbari","year":"2019","unstructured":"Akbari HR, Beheshti F, Sadeghnia HR et al (2019) The effects of captopril on learning and memory impairment induced by scopolamine in rats: anti-oxidative effects. Physiol Pharmacol 23:91\u2013100","journal-title":"Physiol Pharmacol"},{"key":"6706_CR7","doi-asserted-by":"publisher","first-page":"167235","DOI":"10.1155\/2015\/167235","volume":"2015","author":"T Akman","year":"2015","unstructured":"Akman T, Akman L, Erbas O et al (2015) The preventive effect of oxytocin to cisplatin-induced neurotoxicity: an experimental rat model. Biomed Res Int 2015:2015:167235. https:\/\/doi.org\/10.1155\/2015\/167235","journal-title":"Biomed Res Int"},{"key":"6706_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.NEURO.2021.10.002","volume":"88","author":"AE Ali","year":"2022","unstructured":"Ali AE, Elsherbiny DM, Azab SS, El-Demerdash E (2022) The diuretic amiloride attenuates doxorubicin-induced chemobrain in rats: behavioral and mechanistic study. Neurotoxicology 88:1\u201313. https:\/\/doi.org\/10.1016\/J.NEURO.2021.10.002","journal-title":"Neurotoxicology"},{"key":"6706_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12906-017-1976-9","volume":"17","author":"MM Almutairi","year":"2017","unstructured":"Almutairi MM, Alanazi WA, Alshammari MA et al (2017) Neuro-protective effect of rutin against cisplatin-induced neurotoxic rat model. BMC Complement Altern Med 17:1\u20139. https:\/\/doi.org\/10.1186\/S12906-017-1976-9","journal-title":"BMC Complement Altern Med"},{"key":"6706_CR10","doi-asserted-by":"publisher","unstructured":"Amidi A, Hosseini SMH, Leemans A et al (2017) Changes in Brain Structural Networks and Cognitive functions in Testicular Cancer patients receiving cisplatin-based chemotherapy. J Natl Cancer Inst 109(12). https:\/\/doi.org\/10.1093\/JNCI\/DJX085","DOI":"10.1093\/JNCI\/DJX085"},{"key":"6706_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/S12640-019-00095-X","volume":"37","author":"MH Arafa","year":"2020","unstructured":"Arafa MH, Atteia HH (2020) Protective role of Epigallocatechin Gallate in a rat model of Cisplatin-Induced cerebral inflammation and oxidative damage: impact of modulating NF-\u03baB and Nrf2. Neurotox Res 37:380\u2013396. https:\/\/doi.org\/10.1007\/S12640-019-00095-X","journal-title":"Neurotox Res"},{"key":"6706_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/J.EXPNEUROL.2006.03.034","volume":"201","author":"D Avella","year":"2006","unstructured":"Avella D, Pisu MB, Roda E et al (2006) Reorganization of the rat cerebellar cortex during postnatal development following cisplatin treatment. Exp Neurol 201:131\u2013143. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2006.03.034","journal-title":"Exp Neurol"},{"key":"6706_CR13","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1007\/S12035-019-1589-Z","volume":"56","author":"C Bagnall-Moreau","year":"2019","unstructured":"Bagnall-Moreau C, Chaudhry S, Salas-Ramirez K et al (2019) Chemotherapy induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus. Mol Neurobiol 56:7159\u20137172. https:\/\/doi.org\/10.1007\/S12035-019-1589-Z","journal-title":"Mol Neurobiol"},{"key":"6706_CR14","unstructured":"Bancroft JD, Gamble M (2013) Theory and Practice of Histological Techniques. 7th Edition, Churchill Livingstone of Elsevier, Philadelphia, 172\u2013186"},{"key":"6706_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/187152411796011303","volume":"11","author":"G Barreto","year":"2011","unstructured":"Barreto G, White RE, Ouyang Y et al (2011) Astrocytes: targets for Neuroprotection in Stroke. Cent Nerv Syst Agents Med Chem 11:164\u2013173. https:\/\/doi.org\/10.2174\/187152411796011303","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"6706_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2478\/S13380-012-0027-8\/XML","volume":"3","author":"BT Baune","year":"2012","unstructured":"Baune BT, Camara M, Lou, Eyre H et al (2012) Tumour necrosis factor - ALPHA mediated mechanisms of cognitive dysfunction. Translational Neurosci 3:263\u2013277. https:\/\/doi.org\/10.2478\/S13380-012-0027-8\/XML","journal-title":"Translational Neurosci"},{"key":"6706_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/01902148.2018.1473530","volume":"44","author":"J Boskabadi","year":"2018","unstructured":"Boskabadi J, Mokhtari-Zaer A, Abareshi A et al (2018) The effect of captopril on lipopolysaccharide-induced lung inflammation. Exp Lung Res 44:191\u2013200. https:\/\/doi.org\/10.1080\/01902148.2018.1473530","journal-title":"Exp Lung Res"},{"issue":"4","key":"6706_CR18","first-page":"97","volume":"11","author":"A Brown","year":"2019","unstructured":"Brown A, Kumar S, Tchounwou PB (2019) Cisplatin-based chemotherapy of human cancers. J cancer Sci Therapy 11(4):97","journal-title":"J cancer Sci Therapy"},{"key":"6706_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/J.CNR.2006.09.004","volume":"6","author":"MJ Carson","year":"2006","unstructured":"Carson MJ, Cameron Thrash J, Walter B (2006) The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res 6:237\u2013245. https:\/\/doi.org\/10.1016\/J.CNR.2006.09.004","journal-title":"Clin Neurosci Res"},{"key":"6706_CR20","doi-asserted-by":"publisher","first-page":"20201270256","DOI":"10.1155\/2020\/1270256","volume":"4","author":"G Cenini","year":"2020","unstructured":"Cenini G, Lloret A, Cascella R (2020) Oxidative stress and mitochondrial damage in neurodegenerative diseases: from Molecular mechanisms to targeted therapies. Oxidative Med Cell Longev 4:20201270256. https:\/\/doi.org\/10.1155\/2020\/1270256","journal-title":"Oxidative Med Cell Longev"},{"issue":"9","key":"6706_CR21","doi-asserted-by":"publisher","first-page":"e45250","DOI":"10.1371\/JOURNAL.PONE.0045250","volume":"7","author":"F Cerbai","year":"2012","unstructured":"Cerbai F, Lana D, Nosi D et al (2012) The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. PLoS ONE 7(9):e45250. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0045250","journal-title":"PLoS ONE"},{"key":"6706_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/13803395.2018.1546381","volume":"41","author":"N Cerulla","year":"2019","unstructured":"Cerulla N, Arcusa \u00c0, Navarro JB et al (2019) Cognitive impairment following chemotherapy for breast cancer: the impact of practice effect on results. J Clin Exp Neuropsychol 41:290\u2013299. https:\/\/doi.org\/10.1080\/13803395.2018.1546381","journal-title":"J Clin Exp Neuropsychol"},{"key":"6706_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/J.JGR.2017.07.009","volume":"43","author":"C Chen","year":"2019","unstructured":"Chen C, Zhang H, Xu H et al (2019) Ginsenoside Rb1 ameliorates cisplatin-induced learning and memory impairments. J Ginseng Res 43:499\u2013507. https:\/\/doi.org\/10.1016\/J.JGR.2017.07.009","journal-title":"J Ginseng Res"},{"key":"6706_CR24","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2174\/1570159X18666200221113842","volume":"18","author":"A Das","year":"2020","unstructured":"Das A, Ranadive N, Kinra M et al (2020) An overview on chemotherapy-induced cognitive impairment and potential role of antidepressants. Curr Neuropharmacol 18:838\u2013851. https:\/\/doi.org\/10.2174\/1570159X18666200221113842","journal-title":"Curr Neuropharmacol"},{"key":"6706_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/J.BRAINRES.2016.05.013","volume":"1644","author":"WH De Oliveira","year":"2016","unstructured":"De Oliveira WH, De Santana Nunes AK, De Fran\u00e7a MER et al (2016) Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice. Brain Res 1644:149\u2013160. https:\/\/doi.org\/10.1016\/J.BRAINRES.2016.05.013","journal-title":"Brain Res"},{"key":"6706_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/S12974-022-02587-8","volume":"19","author":"X Dong","year":"2022","unstructured":"Dong X, Fan J, Lin D et al (2022) Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis. J Neuroinflamm 19:226. https:\/\/doi.org\/10.1186\/S12974-022-02587-8","journal-title":"J Neuroinflamm"},{"key":"6706_CR75","doi-asserted-by":"publisher","first-page":"111079","DOI":"10.1016\/J.FCT.2019.111079","volume":"136","author":"NAG dos Santos","year":"2020","unstructured":"dos Santos NAG, Ferreira RS, dos Santos AC (2020) Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food Chem Toxicology: Int J Published Br Industrial Biol Res Association 136:111079. https:\/\/doi.org\/10.1016\/J.FCT.2019.111079","journal-title":"Food Chem Toxicology: Int J Published Br Industrial Biol Res Association"},{"key":"6706_CR27","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1007\/S12035-017-0797-7","volume":"55","author":"SE El-Agamy","year":"2018","unstructured":"El-Agamy SE, Abdel-Aziz AK, Wahdan S et al (2018) Astaxanthin ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in experimental rat model: impact on oxidative, inflammatory, and Apoptotic Machineries. Mol Neurobiol 55:5727\u20135740. https:\/\/doi.org\/10.1007\/S12035-017-0797-7","journal-title":"Mol Neurobiol"},{"key":"6706_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/J.1755-5922.2010.00218.X","volume":"30","author":"AA Elmarakby","year":"2012","unstructured":"Elmarakby AA, Sullivan JC (2012) Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther 30:49\u201359. https:\/\/doi.org\/10.1111\/J.1755-5922.2010.00218.X","journal-title":"Cardiovasc Ther"},{"key":"6706_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CANCERS12123842","volume":"12","author":"HR Fernandez","year":"2020","unstructured":"Fernandez HR, Varma A, Flowers SA, Rebeck GW (2020) Cancer Chemotherapy related cognitive impairment and the impact of the Alzheimer\u2019s disease risk factor APOE. Cancers 12:1\u201325. https:\/\/doi.org\/10.3390\/CANCERS12123842","journal-title":"Cancers"},{"key":"6706_CR30","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1038\/S41380-022-01716-2","volume":"27","author":"JP Ferrari-Souza","year":"2022","unstructured":"Ferrari-Souza JP, Ferreira PCL, Bellaver B et al (2022) Astrocyte biomarker signatures of amyloid-\u03b2 and tau pathologies in Alzheimer\u2019s disease. Mol Psychiatry 27:4781\u20134789. https:\/\/doi.org\/10.1038\/S41380-022-01716-2","journal-title":"Mol Psychiatry"},{"key":"6706_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/J.2042-7158.2012.01585.X","volume":"65","author":"AA Fouad","year":"2013","unstructured":"Fouad AA, Al-Mulhim AS, Jresat I, Morsy MA (2013) Protective effects of captopril in diabetic rats exposed to ischemia\/reperfusion renal injury. J Pharm Pharmacol 65:243\u2013252. https:\/\/doi.org\/10.1111\/J.2042-7158.2012.01585.X","journal-title":"J Pharm Pharmacol"},{"key":"6706_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/J.CBI.2018.08.011","volume":"294","author":"BCW Fulco","year":"2018","unstructured":"Fulco BCW, Jung JTK, Chagas PM et al (2018) Pattern differences between newborn and adult rats in cisplatin-induced hepatorenal toxicity. Chemico-Biol Interact 294:65\u201373. https:\/\/doi.org\/10.1016\/J.CBI.2018.08.011","journal-title":"Chemico-Biol Interact"},{"issue":"11","key":"6706_CR33","doi-asserted-by":"publisher","first-page":"e7338","DOI":"10.1590\/1414-431X20187338","volume":"51","author":"Z Gan","year":"2018","unstructured":"Gan Z, Huang D, Jiang J et al (2018) Captopril alleviates hypertension-induced renal damage, inflammation, and NF-\u03baB activation. Brazilian J Med Biol Res = Revista brasileira de pesquisas medicas e Biologicas 51(11):e7338. https:\/\/doi.org\/10.1590\/1414-431X20187338","journal-title":"Brazilian J Med Biol Res = Revista brasileira de pesquisas medicas e Biologicas"},{"key":"6706_CR34","doi-asserted-by":"publisher","first-page":"e002881","DOI":"10.1136\/BMJOPEN-2013-002881","volume":"3","author":"Y Gao","year":"2013","unstructured":"Gao Y, O\u2019Caoimh R, Healy L et al (2013) Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia. BMJ Open 3:e002881. https:\/\/doi.org\/10.1136\/BMJOPEN-2013-002881","journal-title":"BMJ Open"},{"key":"6706_CR35","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/J.BIOORG.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh S (2019) Cisplatin: the first metal based anticancer drug. Bioorg Chem 88:102925. https:\/\/doi.org\/10.1016\/J.BIOORG.2019.102925","journal-title":"Bioorg Chem"},{"key":"6706_CR36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/S12026-022-09307-7","volume":"70","author":"P Gupta","year":"2022","unstructured":"Gupta P, Makkar TK, Goel L, Pahuja M (2022) Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity. Immunol Res 70:725\u2013741. https:\/\/doi.org\/10.1007\/S12026-022-09307-7","journal-title":"Immunol Res"},{"issue":"1","key":"6706_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/S12915-024-01827-Y","volume":"22","author":"E Hannon","year":"2024","unstructured":"Hannon E, Dempster EL, Davies JP et al (2024) Quantifying the proportion of different cell types in the human cortex using DNA methylation profiles. BMC Biol 22(1):17. https:\/\/doi.org\/10.1186\/S12915-024-01827-Y","journal-title":"BMC Biol"},{"key":"6706_CR38","doi-asserted-by":"publisher","first-page":"116875","DOI":"10.1016\/J.TAAP.2024.116875","volume":"485","author":"MM Hassan","year":"2024","unstructured":"Hassan MM, Wahdan SA, El-Naga RN et al (2024) Ondansetron attenuates cisplatin-induced behavioral and cognitive impairment through downregulation of NOD-like receptor inflammasome pathway. Toxicol Appl Pharmcol 485:116875. https:\/\/doi.org\/10.1016\/J.TAAP.2024.116875","journal-title":"Toxicol Appl Pharmcol"},{"issue":"8","key":"6706_CR39","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/S11010-023-04805-0","volume":"479","author":"KM Ibrahim","year":"2024","unstructured":"Ibrahim KM, Darwish SF, Mantawy EM, El-demerdash E (2024) Molecular mechanisms underlying cyclophosphamide-induced cognitive impairment and strategies for neuroprotection in preclinical models. Mol Cell Biochem 479(8):1873\u20131893. https:\/\/doi.org\/10.1007\/S11010-023-04805-0","journal-title":"Mol Cell Biochem"},{"key":"6706_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.54548\/NJPS.V37I1.3","volume":"37","author":"IO Ishola","year":"2022","unstructured":"Ishola IO, Afolayan OO, Badru WA et al (2022) Angiotensin converting enzyme inhibitor captopril prevents neuronal overexpression of amyloid-beta and alpha-synuclein in Drosophila melanogaster genetic models of neurodegenerative diseases. Nigerian J Physiological Sciences: Official Publication Physiological Soc Nigeria 37:21\u201328. https:\/\/doi.org\/10.54548\/NJPS.V37I1.3","journal-title":"Nigerian J Physiological Sciences: Official Publication Physiological Soc Nigeria"},{"key":"6706_CR42","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1158\/1078-0432.CCR-04-1807","volume":"11","author":"SS Jacobs","year":"2005","unstructured":"Jacobs SS, Fox E, Dennie C et al (2005) Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Clin cancer Research: Official J Am Association Cancer Res 11:1669\u20131674. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-1807","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"key":"6706_CR41","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/S00280-009-1085-7","volume":"65","author":"S Jacobs","year":"2010","unstructured":"Jacobs S, McCully CL, Murphy RF et al (2010) Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates. Cancer Chemother Pharmacol 65:817\u2013824. https:\/\/doi.org\/10.1007\/S00280-009-1085-7","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"6706_CR43","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/PH16081165","volume":"16","author":"PK Jaiswara","year":"2023","unstructured":"Jaiswara PK, Shukla SK (2023) Chemotherapy-mediated neuronal aberration. Pharmaceuticals (Basel Switzerland) 16(8):1165. https:\/\/doi.org\/10.3390\/PH16081165","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"key":"6706_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/09540261.2013.864260","volume":"26","author":"MC Janelsins","year":"2014","unstructured":"Janelsins MC, Kesler SR, Ahles TA, Morrow GR (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (Abingdon) 26:102\u2013113. https:\/\/doi.org\/10.3109\/09540261.2013.864260","journal-title":"Int Rev Psychiatry (Abingdon)"},{"key":"6706_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/J.EJPHAR.2016.08.003","volume":"791","author":"A Jangra","year":"2016","unstructured":"Jangra A, Kwatra M, Singh T et al (2016) Edaravone alleviates cisplatin-induced neurobehavioral deficits via modulation of oxidative stress and inflammatory mediators in the rat hippocampus. Eur J Pharmacol 791:51\u201361. https:\/\/doi.org\/10.1016\/J.EJPHAR.2016.08.003","journal-title":"Eur J Pharmacol"},{"key":"6706_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/J.BBR.2016.11.013","volume":"319","author":"T John","year":"2017","unstructured":"John T, Lomeli N, Bota DA (2017) Systemic cisplatin exposure during infancy and adolescence causes impaired cognitive function in adulthood. Behav Brain Res 319:200\u2013206. https:\/\/doi.org\/10.1016\/J.BBR.2016.11.013","journal-title":"Behav Brain Res"},{"key":"6706_CR47","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/J.CBPC.2006.11.001","volume":"144","author":"K Kalia","year":"2007","unstructured":"Kalia K, Narula GD, Kannan GM, Flora SJS (2007) Effects of combined administration of captopril and DMSA on arsenite induced oxidative stress and blood and tissue arsenic concentration in rats. Comp Biochem Physiol Toxicol Pharmacology: CBP 144:372\u2013379. https:\/\/doi.org\/10.1016\/J.CBPC.2006.11.001","journal-title":"Comp Biochem Physiol Toxicol Pharmacology: CBP"},{"key":"6706_CR48","first-page":"514","volume":"43","author":"A Karimani","year":"2018","unstructured":"Karimani A, Mamashkhani Y, Jafari AM et al (2018) Captopril attenuates Diazinon-Induced oxidative stress: a subchronic study in rats. Iran J Med Sci 43:514\u2013522","journal-title":"Iran J Med Sci"},{"issue":"9","key":"6706_CR49","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/CELLS12091309","volume":"12","author":"KY Kim","year":"2023","unstructured":"Kim KY, Shin KY, Chang KA (2023) GFAP as a potential biomarker for Alzheimer\u2019s Disease: a systematic review and Meta-analysis. Cells 12(9):1309. https:\/\/doi.org\/10.3390\/CELLS12091309","journal-title":"Cells"},{"key":"6706_CR50","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/J.NURT.2010.07.006","volume":"7","author":"HK Kimelberg","year":"2010","unstructured":"Kimelberg HK, Nedergaard M (2010) Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics: J Am Soc Experimental Neurother 7:338\u2013353. https:\/\/doi.org\/10.1016\/J.NURT.2010.07.006","journal-title":"Neurotherapeutics: J Am Soc Experimental Neurother"},{"issue":"11","key":"6706_CR51","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/S41419-019-2081-4","volume":"10","author":"M Kleih","year":"2019","unstructured":"Kleih M, B\u00f6pple K, Dong M et al (2019) Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death Dis 10(11):851. https:\/\/doi.org\/10.1038\/S41419-019-2081-4","journal-title":"Cell Death Dis"},{"key":"6706_CR52","doi-asserted-by":"publisher","unstructured":"Kumburovic I, Selakovic D, Juric T et al (2019) Antioxidant effects of Satureja hortensis L. Attenuate the Anxiogenic Effect of Cisplatin in rats. Oxidative medicine and cellular longevity 2019:8307196. https:\/\/doi.org\/10.1155\/2019\/8307196","DOI":"10.1155\/2019\/8307196"},{"issue":"6","key":"6706_CR53","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/CSHPERSPECT.A001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1(6):a001651. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A001651","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"6706_CR54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","volume":"7","author":"K Lingappan","year":"2018","unstructured":"Lingappan K (2018) NF-\u03baB in oxidative stress. Curr Opin Toxicol 7:81\u201386. https:\/\/doi.org\/10.1016\/j.cotox.2017.11.002","journal-title":"Curr Opin Toxicol"},{"key":"6706_CR56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/J.BBR.2015.07.058","volume":"294","author":"Y Liu","year":"2015","unstructured":"Liu Y, Sun JD, Song LK et al (2015) Environment-contact administration of rotenone: a new rodent model of Parkinson\u2019s disease. Behav Brain Res 294:149\u2013161. https:\/\/doi.org\/10.1016\/J.BBR.2015.07.058","journal-title":"Behav Brain Res"},{"key":"6706_CR55","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/SIGTRANS.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Therapy 2:17023. https:\/\/doi.org\/10.1038\/SIGTRANS.2017.23","journal-title":"Signal Transduct Target Therapy"},{"key":"6706_CR57","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/J.FREERADBIOMED.2016.11.046","volume":"102","author":"N Lomeli","year":"2017","unstructured":"Lomeli N, Di K, Czerniawski J et al (2017) Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats. Free Radic Biol Med 102:274\u2013286. https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2016.11.046","journal-title":"Free Radic Biol Med"},{"key":"6706_CR58","doi-asserted-by":"publisher","first-page":"135720","DOI":"10.1016\/J.NEULET.2021.135720","volume":"749","author":"N Lomeli","year":"2021","unstructured":"Lomeli N, Lepe J, Gupta K, Bota DA (2021) Cognitive complications of cancer and cancer-related treatments - novel paradigms. Neurosci Lett 749:135720. https:\/\/doi.org\/10.1016\/J.NEULET.2021.135720","journal-title":"Neurosci Lett"},{"key":"6706_CR59","doi-asserted-by":"publisher","first-page":"114238","DOI":"10.1016\/J.BIOPHA.2023.114238","volume":"159","author":"AMA Mahmoud","year":"2023","unstructured":"Mahmoud AMA, Mantawy EM, Wahdan SA et al (2023) Vildagliptin restores cognitive function and mitigates hippocampal neuronal apoptosis in cisplatin-induced chemo-brain: imperative roles of AMPK\/Akt\/CREB\/ BDNF signaling cascades. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie 159:114238\u2013114238. https:\/\/doi.org\/10.1016\/J.BIOPHA.2023.114238","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"6706_CR60","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/J.JACC.2018.01.058","volume":"71","author":"FH Messerli","year":"2018","unstructured":"Messerli FH, Bangalore S, Bavishi C, Rimoldi SF (2018) Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use? J Am Coll Cardiol 71:1474\u20131482. https:\/\/doi.org\/10.1016\/J.JACC.2018.01.058","journal-title":"J Am Coll Cardiol"},{"issue":"123","key":"6706_CR61","doi-asserted-by":"publisher","first-page":"55523","DOI":"10.3791\/55523","volume":"2017","author":"CJ Miedel","year":"2017","unstructured":"Miedel CJ, Patton JM, Miedel AN et al (2017) Assessment of spontaneous alternation, Novel Object Recognition and limb clasping in transgenic mouse models of Amyloid-\u03b2 and Tau Neuropathology. J Visualized Experiments: JoVE 2017(123):55523. https:\/\/doi.org\/10.3791\/55523","journal-title":"J Visualized Experiments: JoVE"},{"key":"6706_CR62","first-page":"163","volume":"1","author":"JS Miners","year":"2009","unstructured":"Miners JS, Ashby E, Baig S et al (2009) Angiotensin-converting enzyme levels and activity in Alzheimer\u2019s disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Translational Res 1:163\u2013177","journal-title":"Am J Translational Res"},{"key":"6706_CR63","doi-asserted-by":"publisher","first-page":"169649","DOI":"10.1155\/2012\/169649","volume":"2012:2012","author":"M Mogi","year":"2012","unstructured":"Mogi M, Iwanami J, Horiuchi M (2012) Roles of brain angiotensin II in cognitive function and dementia. Int J Hypertens 2012:2012:169649. https:\/\/doi.org\/10.1155\/2012\/169649","journal-title":"Int J Hypertens"},{"key":"6706_CR64","doi-asserted-by":"publisher","first-page":"172729","DOI":"10.1016\/J.EJPHAR.2019.172729","volume":"865","author":"F Mostafa","year":"2019","unstructured":"Mostafa F, Mantawy EM, Azab SS, El-Demerdash E (2019) The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach. Eur J Pharmacol 865:172729. https:\/\/doi.org\/10.1016\/J.EJPHAR.2019.172729","journal-title":"Eur J Pharmacol"},{"key":"6706_CR65","doi-asserted-by":"publisher","first-page":"118071","DOI":"10.1016\/J.LFS.2020.118071","volume":"258","author":"NM Mounier","year":"2020","unstructured":"Mounier NM, Abdel-Maged AES, Wahdan SA et al (2020) Chemotherapy-induced cognitive impairment (CICI): an overview of etiology and pathogenesis. Life Sci 258:118071. https:\/\/doi.org\/10.1016\/J.LFS.2020.118071","journal-title":"Life Sci"},{"key":"6706_CR66","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/J.NEUROPHARM.2006.03.004","volume":"51","author":"A Mu\u00f1oz","year":"2006","unstructured":"Mu\u00f1oz A, Rey P, Guerra MJ et al (2006) Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology 51:112\u2013120. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2006.03.004","journal-title":"Neuropharmacology"},{"key":"6706_CR67","doi-asserted-by":"publisher","first-page":"770413","DOI":"10.3389\/FMOLB.2021.770413","volume":"8","author":"Z Orsz\u00e1ghov\u00e1","year":"2021","unstructured":"Orsz\u00e1ghov\u00e1 Z, Mego M, Chovanec M (2021) Long-term cognitive dysfunction in Cancer survivors. Front Mol Biosci 8:770413. https:\/\/doi.org\/10.3389\/FMOLB.2021.770413","journal-title":"Front Mol Biosci"},{"key":"6706_CR68","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/J.BIOPHA.2018.03.051","volume":"102","author":"O Owoeye","year":"2018","unstructured":"Owoeye O, Adedara IA, Farombi EO (2018) Pretreatment with taurine prevented brain injury and exploratory behaviour associated with administration of anticancer drug cisplatin in rats. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie 102:375\u2013384. https:\/\/doi.org\/10.1016\/J.BIOPHA.2018.03.051","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"6706_CR69","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/J.IJDEVNEU.2014.10.006","volume":"40","author":"VM Piccolini","year":"2015","unstructured":"Piccolini VM, Esposito A, Dal Bo V et al (2015) Cerebellum neurotransmission during postnatal development: [Pt(o,O\u2019-acac)(\u03b3-acac)(DMS)] vs cisplatin and neurotoxicity. Int J Dev Neuroscience: Official J Int Soc Dev Neurosci 40:24\u201334. https:\/\/doi.org\/10.1016\/J.IJDEVNEU.2014.10.006","journal-title":"Int J Dev Neuroscience: Official J Int Soc Dev Neurosci"},{"key":"6706_CR70","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1021\/ACS.CHEMRESTOX.9B00204","volume":"32","author":"L Qi","year":"2019","unstructured":"Qi L, Luo Q, Zhang Y et al (2019) Advances in Toxicological Research of the Anticancer Drug Cisplatin. Chem Res Toxicol 32:1469\u20131486. https:\/\/doi.org\/10.1021\/ACS.CHEMRESTOX.9B00204","journal-title":"Chem Res Toxicol"},{"key":"6706_CR71","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.BBR.2016.07.043","volume":"315","author":"C Rendeiro","year":"2016","unstructured":"Rendeiro C, Sheriff A, Bhattacharya TK et al (2016) Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer. Behav Brain Res 315:10\u201322. https:\/\/doi.org\/10.1016\/J.BBR.2016.07.043","journal-title":"Behav Brain Res"},{"issue":"21","key":"6706_CR72","doi-asserted-by":"publisher","first-page":"13630","DOI":"10.3390\/IJMS232113630","volume":"23","author":"M Rodr\u00edguez-Giraldo","year":"2022","unstructured":"Rodr\u00edguez-Giraldo M, Gonz\u00e1lez-Reyes RE, Ram\u00edrez-Guerrero S et al (2022) Astrocytes as a therapeutic target in Alzheimer\u2019s Disease-Comprehensive Review and recent developments. Int J Mol Sci 23(21):13630. https:\/\/doi.org\/10.3390\/IJMS232113630","journal-title":"Int J Mol Sci"},{"key":"6706_CR73","doi-asserted-by":"publisher","first-page":"115323","DOI":"10.1016\/J.BCP.2022.115323","volume":"206","author":"AMP Romani","year":"2022","unstructured":"Romani AMP (2022) Cisplatin in cancer treatment. Biochem Pharmacol 206:115323. https:\/\/doi.org\/10.1016\/J.BCP.2022.115323","journal-title":"Biochem Pharmacol"},{"key":"6706_CR74","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/0022-3859.188553","volume":"62","author":"K Rygiel","year":"2016","unstructured":"Rygiel K (2016) Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer\u2019s disease? An overview of research evidence in the elderly patient population. J Postgrad Med 62:242\u2013248. https:\/\/doi.org\/10.4103\/0022-3859.188553","journal-title":"J Postgrad Med"},{"key":"6706_CR76","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3389\/FIMMU.2018.01195","volume":"9","author":"JC Santos","year":"2018","unstructured":"Santos JC, Pyter LM (2018) Neuroimmunology of behavioral comorbidities Associated with Cancer and Cancer treatments. Front Immunol 9:1195. https:\/\/doi.org\/10.3389\/FIMMU.2018.01195","journal-title":"Front Immunol"},{"key":"6706_CR77","doi-asserted-by":"publisher","first-page":"113290","DOI":"10.1016\/J.BBR.2021.113290","volume":"408","author":"S Saral","year":"2021","unstructured":"Saral S, Top\u00e7u A, Alkanat M et al (2021) Apelin-13 activates the hippocampal BDNF\/TrkB signaling pathway and suppresses neuroinflammation in male rats with cisplatin-induced cognitive dysfunction. Behav Brain Res 408:113290. https:\/\/doi.org\/10.1016\/J.BBR.2021.113290","journal-title":"Behav Brain Res"},{"key":"6706_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ANTIOX9080743","volume":"9","author":"DSA Simpson","year":"2020","unstructured":"Simpson DSA, Oliver PL (2020) ROS Generation in Microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants 9:1\u201327. https:\/\/doi.org\/10.3390\/ANTIOX9080743","journal-title":"Antioxidants"},{"key":"6706_CR79","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/J.IT.2020.07.004","volume":"41","author":"MV Sofroniew","year":"2020","unstructured":"Sofroniew MV (2020) Astrocyte reactivity: subtypes, states and functions in CNS innate immunity. Trends Immunol 41:758\u2013770. https:\/\/doi.org\/10.1016\/J.IT.2020.07.004","journal-title":"Trends Immunol"},{"key":"6706_CR80","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/FNCEL.2018.00114","volume":"12","author":"H Solleiro-Villavicencio","year":"2018","unstructured":"Solleiro-Villavicencio H, Rivas-Arancibia S (2018) Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4\u2009+\u2009T cells in neurodegenerative diseases. Front Cell Neurosci 12:114. https:\/\/doi.org\/10.3389\/FNCEL.2018.00114","journal-title":"Front Cell Neurosci"},{"key":"6706_CR81","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/J.EXPNEUROL.2013.10.014","volume":"250","author":"PK Sonsalla","year":"2013","unstructured":"Sonsalla PK, Coleman C, Wong LY et al (2013) The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism. Exp Neurol 250:376\u2013383. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2013.10.014","journal-title":"Exp Neurol"},{"issue":"14","key":"6706_CR82","doi-asserted-by":"publisher","first-page":"8373","DOI":"10.3390\/IJERPH19148373","volume":"19","author":"MN Takuathung","year":"2022","unstructured":"Takuathung MN, Sakuludomkan W, Khatsri R et al (2022) Adverse effects of Angiotensin-converting enzyme inhibitors in humans: a systematic review and Meta-analysis of 378 randomized controlled trials. Int J Environ Res Public Health 19(14):8373. https:\/\/doi.org\/10.3390\/IJERPH19148373","journal-title":"Int J Environ Res Public Health"},{"key":"6706_CR83","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/J.NEULET.2018.09.024","volume":"687","author":"MX Tao","year":"2018","unstructured":"Tao MX, Xue X, Gao L et al (2018) Involvement of angiotensin-(1\u20137) in the neuroprotection of captopril against focal cerebral ischemia. Neurosci Lett 687:16\u201321. https:\/\/doi.org\/10.1016\/J.NEULET.2018.09.024","journal-title":"Neurosci Lett"},{"key":"6706_CR84","doi-asserted-by":"publisher","first-page":"135504","DOI":"10.1016\/J.NEULET.2020.135504","volume":"741","author":"AS Taskiran","year":"2021","unstructured":"Taskiran AS, Avci O (2021) Effect of captopril, an angiotensin-converting enzyme inhibitor, on morphine analgesia and tolerance in rats, and elucidating the inflammation and endoplasmic reticulum stress pathway in this effect. Neurosci Lett 741:135504. https:\/\/doi.org\/10.1016\/J.NEULET.2020.135504","journal-title":"Neurosci Lett"},{"issue":"1","key":"6706_CR85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/(SICI)1099-1611(200001\/02)9:1<29::AID-PON428>3.0.CO;2-Z","volume":"9","author":"L Troy","year":"2000","unstructured":"Troy L, McFarland K, Littman-Power S, Kelly BJ, Walpole ET, Wyld D, Thomson D (2000) Cisplatin-based therapy: a neurological and neuropsychological review. Psycho-oncology 9(1):29\u201339. https:\/\/doi.org\/10.1002\/(SICI)1099-1611(200001\/02)9:1%3C;29::AID-PON428%3E;3.0.CO;2-Z","journal-title":"Psycho-oncology"},{"key":"6706_CR86","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","volume":"86","author":"M Uchiyama","year":"1978","unstructured":"Uchiyama M, Mihara M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271\u2013278. https:\/\/doi.org\/10.1016\/0003-2697(78)90342-1","journal-title":"Anal Biochem"},{"key":"6706_CR87","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCRESAHA.121.318051","volume":"128","author":"DCH Van Dorst","year":"2021","unstructured":"Van Dorst DCH, Dobbin SJH, Neves KB et al (2021) Hypertension and Prohypertensive Antineoplastic therapies in Cancer patients. Circul Res 128:1040\u20131061. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318051","journal-title":"Circul Res"},{"key":"6706_CR88","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1002\/CNE.24040","volume":"524","author":"CS von Bartheld","year":"2016","unstructured":"von Bartheld CS, Bahney J, Herculano-Houzel S (2016) The search for true numbers of neurons and glial cells in the human brain: a review of 150 years of cell counting. J Comp Neurol 524:3865\u20133895. https:\/\/doi.org\/10.1002\/CNE.24040","journal-title":"J Comp Neurol"},{"issue":"3","key":"6706_CR89","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/S11906-017-0724-3","volume":"19","author":"KA Walker","year":"2017","unstructured":"Walker KA, Power MC, Gottesman RF (2017) Defining the relationship between hypertension, cognitive decline, and dementia: a review. Curr Hypertens Rep 19:(3):24. https:\/\/doi.org\/10.1007\/S11906-017-0724-3","journal-title":"Curr Hypertens Rep"},{"key":"6706_CR90","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/IJC.30252","volume":"139","author":"HR Wardill","year":"2016","unstructured":"Wardill HR, Mander KA, Van Sebille YZA et al (2016) Cytokine-mediated blood brain barrier disruption as a conduit for cancer\/chemotherapy-associated neurotoxicity and cognitive dysfunction. Int J Cancer 139:2635\u20132645. https:\/\/doi.org\/10.1002\/IJC.30252","journal-title":"Int J Cancer"},{"key":"6706_CR91","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1158\/0008-5472.CAN-20-3290","volume":"81","author":"KH Yoo","year":"2021","unstructured":"Yoo KH, Tang JJ, Rashid MA et al (2021) Nicotinamide mononucleotide prevents cisplatin-induced cognitive impairments. Cancer Res 81:3727\u20133737. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-3290","journal-title":"Cancer Res"},{"issue":"1","key":"6706_CR92","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/S41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z et al (2020) Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Therapy 5(1):209. https:\/\/doi.org\/10.1038\/S41392-020-00312-6","journal-title":"Signal Transduct Target Therapy"},{"key":"6706_CR93","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3892\/ETM.2017.4760","volume":"14","author":"S Zhang","year":"2017","unstructured":"Zhang S, Wu M, Peng C et al (2017) GFAP expression in injured astrocytes in rats. Experimental Therapeutic Med 14:1905\u20131908. https:\/\/doi.org\/10.3892\/ETM.2017.4760","journal-title":"Experimental Therapeutic Med"},{"issue":"3","key":"6706_CR94","doi-asserted-by":"publisher","first-page":"e0151890","DOI":"10.1371\/JOURNAL.PONE.0151890","volume":"11","author":"W Zhou","year":"2016","unstructured":"Zhou W, Kavelaars A, Heijnen CJ (2016) Metformin prevents Cisplatin-Induced Cognitive impairment and brain damage in mice. PLoS ONE 11(3):e0151890. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0151890","journal-title":"PLoS ONE"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-024-06706-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T22:10:02Z","timestamp":1740521402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-024-06706-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6706"],"URL":"https:\/\/doi.org\/10.1007\/s00213-024-06706-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study procedures were conducted and accepted by the Institutional Animal Research Ethics Committee of the Faculty of Pharmacy, Ain Shams University, Cairo, Egypt (No #258).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors proclaim that they have no known contending monetary interests or individual relationships that could have seemed to impact the work stated in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}